159 related articles for article (PubMed ID: 18431376)
1. Rapamycin treatment for a child with germline PTEN mutation.
Marsh DJ; Trahair TN; Martin JL; Chee WY; Walker J; Kirk EP; Baxter RC; Marshall GM
Nat Clin Pract Oncol; 2008 Jun; 5(6):357-61. PubMed ID: 18431376
[TBL] [Abstract][Full Text] [Related]
2. PTEN hamartoma tumor syndromes.
Blumenthal GM; Dennis PA
Eur J Hum Genet; 2008 Nov; 16(11):1289-300. PubMed ID: 18781191
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development.
Tibarewal P; Rathbone V; Constantinou G; Pearce W; Adil M; Varyova Z; Folkes L; Hampson A; Classen GAE; Alves A; Carvalho S; Scudamore CL; Vanhaesebroeck B
J Pathol; 2022 Dec; 258(4):382-394. PubMed ID: 36073856
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus treatment of severe PTEN hamartoma tumor syndrome: case report and in vitro studies.
Schmid GL; Kässner F; Uhlig HH; Körner A; Kratzsch J; Händel N; Zepp FP; Kowalzik F; Laner A; Starke S; Wilhelm FK; Schuster S; Viehweger A; Hirsch W; Kiess W; Garten A
Pediatr Res; 2014 Apr; 75(4):527-34. PubMed ID: 24366516
[TBL] [Abstract][Full Text] [Related]
5. PTEN hamartoma tumor syndrome.
Mester J; Charis E
Handb Clin Neurol; 2015; 132():129-37. PubMed ID: 26564076
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin.
Squarize CH; Castilho RM; Gutkind JS
Cancer Res; 2008 Sep; 68(17):7066-72. PubMed ID: 18757421
[TBL] [Abstract][Full Text] [Related]
7. Hamartoma-like lesions in the mouse retina: an animal model of
Tachibana N; Touahri Y; Dixit R; David LA; Adnani L; Cantrup R; Aavani T; Wong RO; Logan C; Kurek KC; Schuurmans C
Dis Model Mech; 2018 May; 11(5):. PubMed ID: 29716894
[No Abstract] [Full Text] [Related]
8. Cowden syndrome.
Gustafson S; Zbuk KM; Scacheri C; Eng C
Semin Oncol; 2007 Oct; 34(5):428-34. PubMed ID: 17920899
[TBL] [Abstract][Full Text] [Related]
9. Oral rapamycin in the treatment of patients with hamartoma syndromes and PTEN mutation.
Iacobas I; Burrows PE; Adams DM; Sutton VR; Hollier LH; Chintagumpala MM
Pediatr Blood Cancer; 2011 Aug; 57(2):321-3. PubMed ID: 21360661
[TBL] [Abstract][Full Text] [Related]
10. [Cowden disease and the PTEN gene: a successfully clinical and biological combined approach].
Longy M
Bull Cancer; 2001 Dec; 88(12):1153-8. PubMed ID: 11792608
[TBL] [Abstract][Full Text] [Related]
11. Protean PTEN: form and function.
Waite KA; Eng C
Am J Hum Genet; 2002 Apr; 70(4):829-44. PubMed ID: 11875759
[TBL] [Abstract][Full Text] [Related]
12. A Pilot Study of Sirolimus in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in
Komiya T; Blumenthal GM; DeChowdhury R; Fioravanti S; Ballas MS; Morris J; Hornyak TJ; Wank S; Hewitt SM; Morrow B; Memmott RM; Rajan A; Dennis PA
Oncologist; 2019 Dec; 24(12):1510-e1265. PubMed ID: 31350329
[TBL] [Abstract][Full Text] [Related]
13. Primary lung adenocarcinoma occurring in a PTEN related syndrome (Cowden's disease): routine EGFR sequencing also highlights two rare somatic mutations S768I and V769L.
Boespflug A; Couraud S; Bringuier PP; Isaac S; Gérinière L; Perrot E; Edery P; Durieu I; Souquet PJ
Lung Cancer; 2013 Mar; 79(3):318-20. PubMed ID: 23261230
[TBL] [Abstract][Full Text] [Related]
14. PTEN-opathies: from biological insights to evidence-based precision medicine.
Yehia L; Ngeow J; Eng C
J Clin Invest; 2019 Feb; 129(2):452-464. PubMed ID: 30614812
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes.
Rodríguez-Escudero I; Oliver MD; Andrés-Pons A; Molina M; Cid VJ; Pulido R
Hum Mol Genet; 2011 Nov; 20(21):4132-42. PubMed ID: 21828076
[TBL] [Abstract][Full Text] [Related]
16. PTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2.
Levitt RJ; Georgescu MM; Pollak M
Biochem Biophys Res Commun; 2005 Nov; 336(4):1056-61. PubMed ID: 16154532
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus treatment of a PTEN hamartoma tumor syndrome presenting with melena.
Şahin GE; Hoşnut FÖ; Yeşil Ş; Lafcı NG; Gül AE; Şahin G
Turk J Pediatr; 2022; 64(4):766-774. PubMed ID: 36082652
[TBL] [Abstract][Full Text] [Related]
18. Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells.
Wang MY; Lu KV; Zhu S; Dia EQ; Vivanco I; Shackleford GM; Cavenee WK; Mellinghoff IK; Cloughesy TF; Sawyers CL; Mischel PS
Cancer Res; 2006 Aug; 66(16):7864-9. PubMed ID: 16912159
[TBL] [Abstract][Full Text] [Related]
19. [Cowden syndrome, or multiple hamartomatous tumor syndrome, in clinical endocrinology].
Sardinoux M; Raingeard I; Bessis D; Coupier I; Renard E; Bringer J
Ann Endocrinol (Paris); 2010 Sep; 71(4):264-73. PubMed ID: 20627233
[TBL] [Abstract][Full Text] [Related]
20. Toward Systems Pathology for PTEN Diagnostics.
Haddadi N; Travis G; Nassif NT; Simpson AM; Marsh DJ
Cold Spring Harb Perspect Med; 2020 May; 10(5):. PubMed ID: 31615872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
